• Publications
  • Influence
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.
BACKGROUND Antiretroviral (ARV) medications differentially penetrate across the blood-brain barrier into central nervous system (CNS) tissues, potentially influencing their effectiveness in treatingExpand
  • 91
  • 3
The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care
Background The aims were to investigate the hepatitis C (HCV) cascade of care among HIV-infected patients and to identify reasons for not referring for and not initiating HCV therapy after completionExpand
  • 46
  • 3
Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy.
The objectives of this research were to assess prevalence and predictors of early antiretroviral therapy adherence using multiple indicators and to estimate effects of early adherence on subsequentExpand
  • 47
  • 2
Predictors of Missed Hepatitis C Intake Appointments and Failure to Establish Hepatitis C Care Among Patients Living With HIV
Abstract Background We estimated and characterized the proportion of patients living with HIV (PLWH) who missed hepatitis C (HCV) intake appointments and subsequently failed to establish HCV care.Expand
  • 8
  • 2
  • PDF
Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model
BackgroundAccess to Hepatitis C (HCV) care is low among HIV-infected individuals, highlighting the need for new models to deliver care for this population.MethodsRetrospective cohort analysis thatExpand
  • 16
  • 1
  • PDF
The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care
Using an inclusive HCV treatment protocol that encourages prospective engagement in care, HIV-infected patients with and without ongoing barriers to care had similar chances of HCV sustained viralExpand
  • 19
  • 1
Health beliefs and discontinuation of zidovudine therapy.
  • 13
  • 1
High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen
Objectives:To report the rates of grade IV adverse events and hepatitis C virus (HCV) treatment discontinuation associated with the use of telaprevir, pegylated interferon, and ribavirin.Expand
  • 16
Outcomes of pharmacist-assisted management of antiretroviral therapy in patients with HIV infection: A risk-adjusted analysis.
PURPOSE The impact of pharmacist-assisted management (PAM) of pharmacotherapy for patients with human immunodeficiency virus (HIV) infection was investigated. METHODS A retrospective cohortExpand
  • 13
...
1
2
...